Learn About Arthrogryposis Multiplex Congenita Neurogenic Type

What is the definition of Arthrogryposis Multiplex Congenita Neurogenic Type?
Arthrogryposis multiplex congenita neurogenic type (AMCN) refers to the development of multiple joint contractures affecting two or more areas of the body prior to birth. A contracture occurs when a joint becomes permanently fixed in a bent or straightened position, which can impact the function and range of motion of the joint and lead to muscle atrophy. Signs and symptoms of AMCN vary. AMCN can affect upper and lower joints, including the wrists, elbows, fingers, knees, ankles, and hip. In AMCN, arthrogryposis occurs as a result of the abnormal development of cells in the spinal cord (anterior horn cells) or brainstem (motor nuclei). AMCN often occurs sporadically (in a person with no family history of the condition), however families with multiple affected members have also been reported. In most cases, the underlying genetic cause remains unknown.
Save information for later
Sign Up
What are the alternative names for Arthrogryposis Multiplex Congenita Neurogenic Type?
  • Arthrogryposis multiplex congenita neurogenic type
  • AMC, neurogenic type
  • AMCN
  • Neurogenic type of AMC
Who are the top Arthrogryposis Multiplex Congenita Neurogenic Type Local Doctors?
AR
Alexander M. Rossor
Elite
Highly rated in
10
conditions

UCL Queen Square Institute Of Neurology

Queen Square, 
London, ENG, GB 

Alexander Rossor practices in London, United Kingdom. Rossor is rated as an Elite expert by MediFind in the treatment of Arthrogryposis Multiplex Congenita Neurogenic Type. He is also highly rated in 10 other conditions, according to our data. His top areas of expertise are Spinal Muscular Atrophy with Arthrogryposis, Charcot-Marie-Tooth Disease, Arthrogryposis Multiplex Congenita Neurogenic Type, and Spinal Muscular Atrophy (SMA).

FM
Francesco Muntoni
Distinguished
Highly rated in
41
conditions

Great Ormond Street Hospital For Children NHS Trust

London, GB 

Francesco Muntoni practices in London, United Kingdom. Muntoni is rated as a Distinguished expert by MediFind in the treatment of Arthrogryposis Multiplex Congenita Neurogenic Type. He is also highly rated in 41 other conditions, according to our data. His top areas of expertise are Becker Muscular Dystrophy, Duchenne Muscular Dystrophy, Spinal Muscular Atrophy (SMA), and Primary Lateral Sclerosis.

 
 
 
 
Learn about our expert tiers
Learn more
DS
Dr. Debra Shabas
Neurology
Distinguished
Highly rated in
7
conditions
Neurology

NYU Langone Health

Mount Sinai Union Square

10 Union Square E, 
New York, NY 

Debra Shabas is a Neurologist in New York, New York. Shabas has been practicing medicine for over 45 years and is rated as a Distinguished expert by MediFind in the treatment of Arthrogryposis Multiplex Congenita Neurogenic Type. She is also highly rated in 7 other conditions, according to our data. Her top areas of expertise are Arthrogryposis Multiplex Congenita Neurogenic Type, Arthrogryposis Multiplex Congenita, Spastic Diplegia Infantile Type, and Multiple Sclerosis (MS).

View All Doctors
What are the latest Arthrogryposis Multiplex Congenita Neurogenic Type Clinical Trials?
Myoelectric Devices for Restoration of Independent Arm Function in Children and Adults With Neurological Disease and Injury
Enrollment Status: Recruiting
Publish Date: December 05, 2022
Intervention Type: Device
Study Phase: Not Applicable

Summary: The purpose of this study is to investigate if a person with weakness or paralysis in one or both arms, can use the NuroSleeve combined powered arm brace (orthosis) and muscle stimulation system to help restore movement in one arm sufficient to perform daily activities. This study could lead to the development of a product that could allow people with arm weakness or arm paralysis to use the NuroS...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Coordination of Rare Diseases at Sanford
Enrollment Status: Recruiting
Publish Date: June 27, 2022

Summary: CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, international patient registry for all rare diseases. This program allows patients and researchers to connect as easily as possible to help advance treatments and cures for rare diseases. The CoRDS team works with patient advocacy groups, in...

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center

What are the Latest Advances for Arthrogryposis Multiplex Congenita Neurogenic Type?

There is no recent research available for this condition. Please check back because thousands of new papers are published every week and we strive to find and display the most recent relevant research as soon as it is available.